Jon S Odorico, MD
Professor
- Section of Kidney and Pancreas Surgery
- Division of Transplantation
jon@surgery.wisc.edu
(608) 263-0388
Clinical Science Center
600 Highland Avenue
Madison WI 53792
Education
- MD, New York University, School of Medicine, New York, NY, 1987
- Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1994
- Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1992
- Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1994-1996
Honors
Best Doctors in America Award Surgery, Transplantation
Madison Magazine Top Docs 2012 Award Surgery, Transplantation
Clinical Specialties
Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico provides a wide range of services including Kidney Transplant, Pancreas Transplant.
Research Interests
Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab
Clinical Trials
Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
10/18/2018 –present
Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020
Recent Publications
An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United States.
Yoo A, Riedel A, Qian I, Bartosic A, Soltani R, Kibria G, Haririan A, Drachenberg CB, Abrams PL, Odorico JS, Cooper M, Bromberg JS, Scalea JR
Transplant Direct 2023 Apr; 9(4): e1459
[PubMed ID: 36935870]In Vivo CaV3 Channel Inhibition Promotes Maturation of Glucose-Dependent Ca2+ Signaling in Human iPSC-Islets.
Zhao K, Shi Y, Yu J, Yu L, Köhler M, Mael A, Kolton A, Joyce T, Odorico J, Berggren PO, Yang SN
Biomedicines 2023 Mar 07; 11(3)
[PubMed ID: 36979793]Validating expression of beta cell maturation-associated genes in human pancreas development.
Tremmel DM, Mikat AE, Gupta S, Mitchell SA, Curran AM, Menadue JA, Odorico JS, Sackett SD
Front Cell Dev Biol 2023; 11: 1103719
[PubMed ID: 36846594]Higher Fasting Pretransplant C-peptide Levels in Type 2 Diabetics Undergoing Simultaneous Pancreas-kidney Transplantation Are Associated With Posttransplant Pancreatic Graft Dysfunction.
Parajuli S, Mandelbrot D, Aufhauser D, Kaufman D, Odorico J
Transplantation 2023 Apr 01; 107(4): e109-e121
[PubMed ID: 36706060]Genetic Engineering of Immune Evasive Stem Cell-Derived Islets.
Sackett SD, Kaplan SJ, Mitchell SA, Brown ME, Burrack AL, Grey S, Huangfu D, Odorico J
Transpl Int 2022; 35: 10817
[PubMed ID: 36545154]